Elite Pharma Stock Technical Analysis
| ELTP Stock | USD 0.43 0.02 4.44% |
As of the 31st of January, Elite Pharma shows the Mean Deviation of 2.09, standard deviation of 3.06, and Variance of 9.36. Elite Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Elite Pharma, which can be compared to its peers.
Elite Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Elite, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EliteElite |
Elite Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Elite Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Elite Pharma.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Elite Pharma on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Elite Pharma or generate 0.0% return on investment in Elite Pharma over 90 days. Elite Pharma is related to or competes with AB Science, Swedencare, Glass House, Allergy Therapeutics, and Basilea Pharmaceutica. Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, con... More
Elite Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Elite Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Elite Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 19.71 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 4.26 |
Elite Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elite Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Elite Pharma's standard deviation. In reality, there are many statistical measures that can use Elite Pharma historical prices to predict the future Elite Pharma's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.56) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elite Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elite Pharma January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 2.09 | |||
| Coefficient Of Variation | (578.24) | |||
| Standard Deviation | 3.06 | |||
| Variance | 9.36 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 19.71 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 4.26 | |||
| Skewness | (1.44) | |||
| Kurtosis | 6.21 |
Elite Pharma Backtested Returns
Elite Pharma secures Sharpe Ratio (or Efficiency) of -0.17, which denotes the company had a -0.17 % return per unit of risk over the last 3 months. Elite Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Elite Pharma's Variance of 9.36, standard deviation of 3.06, and Mean Deviation of 2.09 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.97, which means possible diversification benefits within a given portfolio. Elite Pharma returns are very sensitive to returns on the market. As the market goes up or down, Elite Pharma is expected to follow. At this point, Elite Pharma has a negative expected return of -0.55%. Please make sure to confirm Elite Pharma's maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Elite Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.64 |
Good predictability
Elite Pharma has good predictability. Overlapping area represents the amount of predictability between Elite Pharma time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Elite Pharma price movement. The serial correlation of 0.64 indicates that roughly 64.0% of current Elite Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.64 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Elite Pharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Elite Pharma Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Elite Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Elite Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Elite Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Elite Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Elite Pharma price pattern first instead of the macroeconomic environment surrounding Elite Pharma. By analyzing Elite Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Elite Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Elite Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Elite Pharma January 31, 2026 Technical Indicators
Most technical analysis of Elite help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Elite from various momentum indicators to cycle indicators. When you analyze Elite charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 2.09 | |||
| Coefficient Of Variation | (578.24) | |||
| Standard Deviation | 3.06 | |||
| Variance | 9.36 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 19.71 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 4.26 | |||
| Skewness | (1.44) | |||
| Kurtosis | 6.21 |
Elite Pharma January 31, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Elite stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.09 | ||
| Daily Balance Of Power | (0.50) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 0.45 | ||
| Day Typical Price | 0.44 | ||
| Price Action Indicator | (0.03) | ||
| Market Facilitation Index | 0.04 |
Additional Tools for Elite OTC Stock Analysis
When running Elite Pharma's price analysis, check to measure Elite Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elite Pharma is operating at the current time. Most of Elite Pharma's value examination focuses on studying past and present price action to predict the probability of Elite Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elite Pharma's price. Additionally, you may evaluate how the addition of Elite Pharma to your portfolios can decrease your overall portfolio volatility.